Novacyt S.A. (LON:NCYT – Get Free Report)’s share price traded up 5% during mid-day trading on Wednesday . The stock traded as high as GBX 72.36 ($0.89) and last traded at GBX 71.40 ($0.88). 137,563 shares traded hands during mid-day trading, an increase of 90% from the average session volume of 72,583 shares. The stock had previously closed at GBX 68 ($0.84).
Novacyt Stock Performance
The firm’s fifty day moving average price is GBX 49.71 and its 200-day moving average price is GBX 53. The company has a current ratio of 5.09, a quick ratio of 4.46 and a debt-to-equity ratio of 0.36. The firm has a market cap of £48.73 million, a price-to-earnings ratio of -191.67 and a beta of -1.73.
Novacyt Company Profile
Novacyt SA, together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.
Further Reading
- Five stocks we like better than Novacyt
- Market Cap Calculator: How to Calculate Market Cap
- 3 Stocks Leading the U.S. Agriculture Comeback
- Why Are Stock Sectors Important to Successful Investing?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Find and Profitably Trade Stocks at 52-Week Lows
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.
